Xylapan 20 mg/ml Solution for Injection
Xylapan 20 mg/ml Solution for Injection
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
Xylapan 20 mg/ml Solution for Injection
Active substance:
- Xylazine hydrochloride
Target species:
-
Cattle
-
Dog
-
Cat
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Xylazine hydrochloride23.31/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal1day
-
Milk0hour
-
-
Dog
-
Cat
-
-
Intravenous use
-
Dog
-
Horse
-
Meat and offal1day
-
-
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- 50 ml Type I, clear glass vial with a rubber stopper and an aluminium cap.
- 10 ml Type I, clear glass vial with a rubber stopper and an aluminium cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Vetoquinol Ireland Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol UK Limited
- Vetoquinol Biowet Sp. z o.o.
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10983/061/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?:
